NCT03831282View on ClinicalTrials.gov

Feasibility and Performance Evaluation of INVSENSOR00024

NACompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions

Evaluation of SpO2 Performance

Interventions

DEVICE

RD SET Neo SpO2

All subjects are enrolled in the experimental group and receive the RD SET Neo SpO2 sensor.

Trial Locations (1)

92868

Children's Hospital of Orange County, Orange

Sponsors

Lead Sponsor

Masimo Corporation

All Listed Sponsors

lead

Masimo Corporation

INDUSTRY

NCT03831282 - Feasibility and Performance Evaluation of INVSENSOR00024 | Biotech Hunter | Biotech Hunter